Related Experiment Video
Updated: Aug 19, 2026

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Are acid secretory tests of diagnostic value in patients with benign-looking gastric ulcers?
Abstract:
In 41 patients in whom endoscopy showed benign gastric ulcer, gastric secretory function was assessed before and after stimulation with pentagastrin (6 micrograms/kg); they were then followed up for a period of 2-4 years. Of these 41 patients, 37 had benign and the remaining 4 malignant ulcers. Of the 37 patients with benign gastric ulcers, 11 had basal achlorhydria but all secreted acid after pentagastrin stimulation. Seven of these 37 patients (19%) secreted less than 5 mmol/h in response to stimulation with pentagastrin. Of the 4 patients with malignant gastric ulcer, 3 had basal achlorhydria. After pentagastrin stimulation 3 of these patients (75%) secreted up to 5 mmol/h and 1 patient secreted 17 mmol/h. Biopsy evidence of malignancy was only obtained after repeat endoscopy and biopsy in 2 of these 4 patients. The present study confirms that a malignant ulcer may simulate a benign ulcer on endoscopy, and shows that the finding of hypochlorhydria in such patients warrants a cautious approach with repeat endoscopy and biopsy to exclude a malignant lesion.
More Related Videos
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...

